VivoSeq
Other

Chronic Wounds

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Chronic Wounds is an early-stage landscape with 0 programs across 1 company. The most active players are StimLabs.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

58/100

Attrition Rate

31/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

StimLabs

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

16

clinical trials

Completed7 · 44%
Terminated4 · 25%
Recruiting2 · 13%
Not yet recruiting1 · 6%
Unknown status1 · 6%
Withdrawn1 · 6%

Clinical Trials

Trial Activity

16 trials

Antibiotic Tumescent For Chronic Wounds
Recruiting·UUniversity of California, Los Angeles·Phase 2·NCT06327113·60 enrolled
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
Recruiting·UUniversity of California, Irvine·Phase 1·NCT05169814·40 enrolled
Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
Not yet recruiting·—·Phase 3·NCT07223892·600 enrolled
Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds
Completed·NNakhia Impex LLC·N/A·NCT05810649·24 enrolled
Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds
Completed·—·N/A·NCT02392390·10 enrolled
Characterisation of Biofilm of the Chronic Wounds
Completed·IInstitut Curie·N/A·NCT02519166·130 enrolled
Absorption and Safety of Topical Timolol to Treat Chronic Wounds
Completed·VVA Northern California Health Care System·N/A·NCT04903366·40 enrolled
Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds
Completed·NNakhia Impex LLC·N/A·NCT05764226·20 enrolled
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Completed·TTower Outpatient Surgical Center·Phase 2·NCT02092870·25 enrolled
A Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue Used for Treatment in Hard-to-Heal Wounds
Completed·SStimLabs·N/A·NCT07215741·23 enrolled
Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds
Terminated·SSchülke & Mayr GmbH·Phase 4·NCT01434914·9 enrolled
Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds
Terminated·IInstitut Curie·Phase 3·NCT02028923·126 enrolled
Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds
Terminated·UUniversity of Utah·Phase 1/2·NCT04438174·1 enrolled
Study to Evaluate Bone Marrow Cells in the Treatment of Chronic Wounds
Terminated·—·Phase 1·NCT02319720·11 enrolled
Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics
Withdrawn·RRWTH Aachen University·Phase 3·NCT04172363
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)